Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
AI Eko smart stethoscope machine learning heart murmurs adult pediatric patients FDA clearance

FDA clears Eko’s latest AI model for heart murmurs

The algorithm works with Eko's smart stethoscopes to help physicians identify and diagnose structural heart murmurs. 

NIH study reveals COVID-19 brain fog may be from immune response

The condition of brain fog that some COVID-19 patients experience could be caused by an immune response to the virus.

COVID-19 a leading cause of death in US, topped only by heart disease and cancer

COVID-19 was the third leading cause of death in the U.S. in both 2020 and 2021, according to the National Institutes of Health.

 

The most successful case to date of a pig organ being transplanted into a human occurred back in January, when specialists at the University of Maryland Medical Center (UMMC) in Baltimore transplanted a modified pig heart into 57-year-old David Bennett. The FDA approved the heart transplant transplant through an emergency authorization typically reserved for experimental procedures seen as a patient’s last chance at survival. Bennett did die of heart failure two months later, but UMMC specialists had been “

FDA may allow clinical trials of pig organ transplants into human patients

The FDA would approve trials on a case-by-case basis, according to an anonymous source close to the situation. 

There has been fear of a small number of patient who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination

COVID-19 vaccines saved 20 million lives

New research illuminates just how effective COVID-19 vaccines were at saving lines––20 million deaths were likely avoided.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

VIDEO: How to build a structural heart program

Charles Davidson, MD, clinical chief of cardiology and medical director of the Bluhm Cardiovascular Institute, Northwestern University, explains what hospitals need to consider when starting a new structural heart program. 

The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting. #AMA #AMA175 #AMAmtg #ASNC

AMA supports reimbursement for pharmacologic stress agent regadenoson

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

COVID-19 vaccines approved for young children

The vaccines were approved for younger populations after evidence revealed their effectiveness for this group.

Displaying 393 - 400 of 714

Around the web

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

AI in Healthcare
Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.